September Is Sickle Cell Awareness Month. While many people are familiar with sickle cell anemia, sickle cell traits have also plagued our community. Sickle cell trait (SCT) is an inherited blood ...

Sickle cell conditions are genetic blood disorders that affect haemoglobin, the molecule in red blood cells responsible for carrying oxygen throughout the body. While both sickle cell trait and sickle ...

West Hartford resident Jean Martin has the sickle cell trait and volunteered to be a part of the study. She said her and her son have the trait but doesn’t know anyone else with sickle cell. Martin is ...

Almost exactly three months to the day that Ole Miss player Bennie Abram collapsed during a workout and passed away several hours later, the cause of his death has finally been released. According to ...

LOS ANGELES — Children with sickle cell anemia are vulnerable to serious infections and stroke, but many do not receive the preventive care that could help them stay healthier longer, according to a ...

Please provide your email address to receive an email when new articles are posted on . Patients with myeloid and monocytic leukemia are at increased risk for leukemia. Future prospective studies are ...

September is National Sickle Cell Anemia Awareness Month. Sickle cell anemia is a disease that is inherited genetically through a trait passed to a child by both parents, affecting the blood cells.

LOS ANGELES (KABC) -- It's been more than a month since the FDA approved two milestone gene-editing treatments for sickle cell disease, but lining up patients for these therapies will be a challenge ...

Adding erythropoietin to hydroxyurea treatment could significantly improve quality of life for patients with sickle cell ...

Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required ...

Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies.

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the presentation of new preclinical data on ...